oxazolidin-2-one has been researched along with Diabetic Foot in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Kalantzi, S; Konsta, E; Loupa, CV; Lykoudi, E; Meimeti, E; Moisoglou, I; Voyatzoglou, ED | 1 |
| Chhibber, S; Kaur, T | 1 |
| Morinet, F | 1 |
| Havlichek, DH; Prokai, L; Scharmen, AE; Smith, CL; Stein, GE; Throckmorton, JK; Weiss, WJ | 1 |
| Drewelow, B; Haase, G; Klammt, S; Majcher-Peszynska, J; Mundkowski, R; Pietsch, A; Sass, M; Schareck, W | 1 |
| Joukhadar, C; Mauric, O; Popovic, M; Scharnagl, E; Schintler, MV; Spendel, S; Traunmüller, F | 1 |
| Huang, DB; Itani, KM; Joseph, W; Lipsky, BA; Myers, DE; Paap, CM; Reisman, A; Weigelt, JA | 1 |
| Kuti, JL; Nicolau, DP; Shepard, A; Wiskirchen, DE | 1 |
| Hodges, G; McCardle, JE; Young, MJ | 1 |
| Sharpe, JN | 1 |
| Boulton, AJ; Bowling, FL; Salgami, EV | 1 |
2 trial(s) available for oxazolidin-2-one and Diabetic Foot
| Article | Year |
|---|---|
Determination of tissue penetration and pharmacokinetics of linezolid in patients with diabetic foot infections using in vivo microdialysis.
Topics: Acetamides; Aged; Diabetic Foot; Humans; L-Lactate Dehydrogenase; Linezolid; Male; Microdialysis; Middle Aged; Oxazolidinones; Thigh; Wound Infection | 2011 |
Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers.
Topics: Acetamides; Aged; Animals; Diabetic Foot; Diabetic Neuropathies; Foot Ulcer; Humans; Larva; Linezolid; Methicillin Resistance; Middle Aged; Oxazolidinones; Patient Selection; Reproducibility of Results; Staphylococcus aureus; Vancomycin | 2007 |
9 other study(ies) available for oxazolidin-2-one and Diabetic Foot
| Article | Year |
|---|---|
Successful Treatment of Diabetic Foot Osteomyelitis with Dalbavancin.
Topics: Anti-Bacterial Agents; Burns; Daptomycin; Diabetes Mellitus, Type 2; Diabetic Foot; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Teicoplanin; Tetrazoles; Tigecycline | 2020 |
Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Diabetes Mellitus, Experimental; Diabetic Foot; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Staphylococcal Skin Infections; Treatment Outcome | 2013 |
[Bacteriophage therapy and diabetic foot ulcer].
Topics: Acetamides; Animals; Anti-Infective Agents; Bacteriophages; Combined Modality Therapy; Diabetes Mellitus, Experimental; Diabetic Foot; Humans; Linezolid; Mice; Mice, Inbred BALB C; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Superinfection | 2013 |
Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Chromatography, Liquid; Diabetic Foot; Female; Humans; Linezolid; Male; Middle Aged; Outpatients; Oxazolidinones; Serum; Skin; Staphylococcus aureus; Streptococcus; Tandem Mass Spectrometry; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.
Topics: Acetamides; Aged; Anti-Infective Agents; Diabetic Foot; Female; Humans; Inflammation; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Permeability; Soft Tissue Infections; Staphylococcal Skin Infections | 2008 |
Linezolid concentrations in infected soft tissue and bone following repetitive doses in diabetic patients with bacterial foot infections.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacterial Infections; Bone and Bones; Diabetes Mellitus, Type 2; Diabetic Foot; Humans; Linezolid; Male; Middle Aged; Osteomyelitis; Oxazolidinones; Plasma; Skin; Soft Tissue Infections | 2010 |
The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Diabetes Complications; Diabetic Foot; Female; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Prospective Studies; Randomized Controlled Trials as Topic; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2011 |
Cost avoidance using linezolid for methicillin-resistant Staphylococcus aureus infections in a specialist diabetes foot clinic.
Topics: Acetamides; Diabetic Foot; Drug Utilization; Health Care Costs; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Skin Infections; Staphylococcus aureus; United Kingdom | 2012 |
Antibiotics as an adjunct to surgical management of lower extremity ulcerations.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Daptomycin; Debridement; Diabetic Foot; Drug Resistance, Microbial; Female; Foot Ulcer; Glycopeptides; Humans; Leg Ulcer; Linezolid; Lipoglycopeptides; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Wound Healing | 2004 |